In cancer, ICAM-1 has been shown to play a role in recruiting integrin β2-expressing immune cells from bloodstream to ICAM-1–expressing tumor, thus initiating cancer-related immune responses throughout oncogenesis [7, 10, 11]. This evidence concerns the gene ICAM1 and neoplasm.